journal article·2022-02Open access

Hierarchically Multivalent Peptide–Nanoparticle Architectures: A Systematic Approach to Engineer Surface Adhesion

Woo‐jin Jeong, Jiyoon Bu, Roya Jafari, Pavel Rehak, Luke J. Kubiatowicz, Adam J. Drelich, Randall H. Owen, Ashita Nair, Piper A. Rawding, Michael J. Poellmann, Caroline M. Hopkins, Petr Král, Seungpyo Hong

Advanced Science· Volume 9· Issue 4

Abstract

Abstract The multivalent binding effect has been the subject of extensive studies to modulate adhesion behaviors of various biological and engineered systems. However, precise control over the strong avidity‐based binding remains a significant challenge. Here, a set of engineering strategies are developed and tested to systematically enhance the multivalent binding of peptides in a stepwise manner. Poly(amidoamine) (PAMAM) dendrimers are employed to increase local peptide densities on a substrate, resulting in hierarchically multivalent architectures (HMAs) that display multivalent dendrimer–peptide conjugates (DPCs) with various configurations. To control binding behaviors, effects of the three major components of the HMAs are investigated: i) poly(ethylene glycol) (PEG) linkers as spacers between conjugated peptides; ii) multiple peptides on the DPCs; and iii) various surface arrangements of HMAs (i.e., a mixture of DPCs each containing different peptides vs DPCs cofunctionalized with multiple peptides). The optimized HMA configuration enables significantly enhanced target cell binding with high selectivity compared to the control surfaces directly conjugated with peptides. The engineering approaches presented herein can be applied individually or in combination, providing guidelines for the effective utilization of biomolecular multivalent interactions using DPC‐based HMAs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Polymer Surface Interaction Studies · Chemical Synthesis and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pharmaceutical Sciences Division and Wisconsin Center for NanoBioSystems (WisCNano) School of Pharmacy University of Wisconsin‐Madison 777 Highland Ave Madison WI 53705 USA

Department of Biological Sciences and Bioengineering Inha University 100 Inha‐ro, Michuhol‐gu Incheon 22212 Republic of Korea

Department of Chemistry University of Illinois at Chicago 845 W Taylor St Chicago IL 60607 USA

Departments of Physics, Pharmaceutical Sciences and Chemical Engineering University of Illinois at Chicago 845 W Taylor St Chicago IL 60607 USA

Department of Biomedical Engineering The University of Wisconsin‐Madison 1550 Engineering Dr. Madison WI 53705 USA

Yonsei Frontier Lab Department of Pharmacy Yonsei University 50 Yonsei‐ro, Seodaemun‐gu Seoul 03722 Republic of Korea

Funding

National Science Foundation · National Research Foundation of Korea

References (59)

Show source-provided references
1. 10.1126/sciadv.aat127310.1126/sciadv.aat1273 ↗
2. 10.1073/pnas.141179811110.1073/pnas.1411798111 ↗
3. 10.1016/S0092-8674(00)00109-410.1016/S0092-8674(00)00109-4 ↗
4. 10.1016/j.coche.2013.01.00310.1016/j.coche.2013.01.003 ↗
5. 10.1016/j.chembiol.2006.11.01510.1016/j.chembiol.2006.11.015 ↗
6. 10.4155/tde.12.7610.4155/tde.12.76 ↗
7. 10.1039/C2CS35219B10.1039/C2CS35219B ↗
8. 10.1038/s41598-018-26643-710.1038/s41598-018-26643-7 ↗
9. 10.1016/j.bpj.2018.03.00710.1016/j.bpj.2018.03.007 ↗
10. 10.1038/nnano.2016.18110.1038/nnano.2016.181 ↗
11. 10.1021/acsmacrolett.6b0074610.1021/acsmacrolett.6b00746 ↗
12. 10.1002/anie.20180900610.1002/anie.201809006 ↗
13. 10.1039/C7CS00877E10.1039/C7CS00877E ↗
14. 10.1002/anie.20170200510.1002/anie.201702005 ↗
15. 10.1186/s40580-018-0170-110.1186/s40580-018-0170-1 ↗
16. 10.1021/jacs.9b1016010.1021/jacs.9b10160 ↗
17. 10.1002/smll.20160166610.1002/smll.201601666 ↗
18. 10.1021/bm500313f10.1021/bm500313f ↗
19. 10.1038/nrd.2018.12510.1038/nrd.2018.125 ↗
20. 10.5946/ce.2013.46.6.60310.5946/ce.2013.46.6.603 ↗
21. 10.1002/anie.20110550810.1002/anie.201105508 ↗
22. 10.1158/0008-5472.CAN-15-294910.1158/0008-5472.CAN-15-2949 ↗
23. 10.1021/acs.nanolett.0c0095010.1021/acs.nanolett.0c00950 ↗
24. 10.1016/j.bios.2020.11225010.1016/j.bios.2020.112250 ↗
25. 10.1021/acs.nanolett.0c0095310.1021/acs.nanolett.0c00953 ↗
26. 10.1021/ma062599e10.1021/ma062599e ↗
27. 10.1016/j.tips.2019.01.00610.1016/j.tips.2019.01.006 ↗
28. 10.1002/adhm.20150072410.1002/adhm.201500724 ↗
29. 10.1016/j.ygyno.2010.07.00510.1016/j.ygyno.2010.07.005 ↗
30. 10.1021/bc500367z10.1021/bc500367z ↗
31. 10.1021/ma501258c10.1021/ma501258c ↗
32. 10.1016/0001-8686(87)85003-010.1016/0001-8686(87)85003-0 ↗
33. 10.1021/jacs.9b0710510.1021/jacs.9b07105 ↗
34. 10.1021/bm801274210.1021/bm8012742 ↗
35. 10.1021/acsnano.6b0270810.1021/acsnano.6b02708 ↗
36. 10.1371/journal.pone.011229210.1371/journal.pone.0112292 ↗
37. 10.1038/nmat505310.1038/nmat5053 ↗
38. 10.1038/s41565-020-0660-210.1038/s41565-020-0660-2 ↗
39. 10.1021/jacs.7b0996710.1021/jacs.7b09967 ↗
40. 10.1073/pnas.15023619710.1073/pnas.150236197 ↗
41. 10.1016/S1359-0294(96)80142-710.1016/S1359-0294(96)80142-7 ↗
42. 10.1016/j.ejmech.2012.09.02410.1016/j.ejmech.2012.09.024 ↗
43. 10.1096/fj.05-4058com10.1096/fj.05-4058com ↗
44. 10.1096/fj.08-11700210.1096/fj.08-117002 ↗
45. 10.1016/j.actbio.2020.11.00910.1016/j.actbio.2020.11.009 ↗
46. 10.1038/ncomms985710.1038/ncomms9857 ↗
47. 10.3892/or.2016.484710.3892/or.2016.4847 ↗
48. 10.1021/la101290r10.1021/la101290r ↗
49. 10.1002/adhm.20170132410.1002/adhm.201701324 ↗
50. 10.1002/bies.20160012310.1002/bies.201600123 ↗
51. 10.1111/j.1747-0285.2009.00847.x10.1111/j.1747-0285.2009.00847.x ↗
52. 10.1016/j.cis.2018.06.00510.1016/j.cis.2018.06.005 ↗
53. 10.1021/acs.biomac.6b0181610.1021/acs.biomac.6b01816 ↗
54. 10.1021/acs.molpharmaceut.5b0094610.1021/acs.molpharmaceut.5b00946 ↗
55. 10.1039/C8CS00022K10.1039/C8CS00022K ↗
56. 10.1002/jcc.2028910.1002/jcc.20289 ↗
57. 10.1021/ci300363c10.1021/ci300363c ↗
58. 10.1021/ja036959e10.1021/ja036959e ↗
59. 10.1063/1.46439710.1063/1.464397 ↗